Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
---|---|---|---|---|---|
16.09. | FluoGuide A/S: FluoGuide Receives Positive FDA Feedback on FG001 in High-Grade Glioma | 207 | ACCESS Newswire | KØBENHAVN, DK / ACCESS Newswire / September 16, 2025 / FluoGuide A/S ("FluoGuide" or the "Company") received positive feedback and alignment with the FDA at a pre-IND consultation on its U.S. clinical... ► Artikel lesen | |
28.08. | FluoGuide A/S Publishes Interim Report H1 2025 | 160 | ACCESS Newswire | KØBENHAVN, DK / ACCESS Newswire / August 28, 2025 / FluoGuide A/S (STO:FLUO) - Copenhagen, Denmark, 28 August 2025 - FluoGuide A/S ("FluoGuide" or the "Company") today releases its results for the period... ► Artikel lesen | |
22.08. | Invitation to FluoGuide A/S Webcast on 28 August 2025 | 233 | ACCESS Newswire | KØBENHAVN, DK / ACCESS Newswire / August 22, 2025 / FluoGuide A/S (STO:FLUO) - FluoGuide A/S will publish its Interim Report Q2 2025 on Thursday 28 August 2025.The following event will take place later... ► Artikel lesen | |
21.07. | FluoGuide A/S: FluoGuide Enters Collaboration with Global MedTech Company Olympus | 421 | ACCESS Newswire | COPENHAGEN, DK / ACCESS Newswire / July 21, 2025 / FluoGuide A/S (STO:FLUO) ("FluoGuide" or the "Company"), a biotech company specializing in precision cancer surgery, announces a collaboration with... ► Artikel lesen | |
03.07. | FluoGuide A/S: Update on 2025 Outlook and Company progress | 174 | GlobeNewswire (Europe) | Copenhagen, Denmark, 3 July 2025 - FluoGuide A/S ("FluoGuide" or the "Company"), a clinical-stage biotech company focused on precision cancer surgery, is pleased to share an update on the 2025 Outlook... ► Artikel lesen | |
FLUOGUIDE Aktie jetzt für 0€ handeln | |||||
10.06. | FluoGuide A/S: FG001 clinical data in High-Grade Glioma is now published in Neurosurgery | 549 | ACCESS Newswire | KØBENHAVN, DK / ACCESS Newswire / June 10, 2025 / FluoGuide A/S (STO:FLUO) - Copenhagen, Denmark - FluoGuide A/S ("FluoGuide" or the "Company"), a clinical-stage biotech company focused on precision... ► Artikel lesen | |
28.05. | FluoGuide A/S: FluoGuide A/S publishes interim report for the period January - March 2025 - On track - first patients enrolled in CT-005 | 199 | GlobeNewswire (Europe) | Copenhagen, Denmark, 28 May 2025 - FluoGuide A/S ("FluoGuide" or the "Company") today releases its results for the period 1 January - 31 March 2025. The Q1 report is available as an attached document... ► Artikel lesen | |
15.04. | FluoGuide A/S: FluoGuide includes first patient in phase II trial of FG001 for head and neck cancer | 187 | GlobeNewswire (Europe) | Copenhagen, Denmark - FluoGuide A/S ("FluoGuide" or the "Company"), a biotech company specializing in precision cancer surgery, is pleased to announce the inclusion of the first patient in its phase... ► Artikel lesen | |
27.03. | Minutes from Annual General Meeting in FluoGuide A/S | 297 | ACCESS Newswire | COPENHAGEN, DENMARK / ACCESS Newswire / March 27, 2025 / FluoGuide A/S (STO:FLUO) ("FluoGuide" or the "Company" held its annual general meeting on 27 March 2025.To the shareholders of FluoGuide A/S.The... ► Artikel lesen | |
12.03. | Notice of Annual General Meeting in FluoGuide A/S | 358 | ACCESS Newswire | KØBENHAVN, DK / ACCESS Newswire / March 12, 2025 / FluoGuide A/S (STO:FLUO)The board of directors hereby convenes the Annual General Meeting of FluoGuide A/S, company registration (CVR) no. 39 29 64... ► Artikel lesen | |
27.02. | FluoGuide A/S Publishes Interim Report for the Period January - December 2024 | 276 | ACCESS Newswire | KØBENHAVN, DENMARK / ACCESS Newswire / February 27, 2025 / FluoGuide A/S (STO:FLUO) Copenhagen, Denmark, 27 February 2025 - Fluoguide A/S ("FluoGuide" or the "Company") today releases its results for... ► Artikel lesen | |
27.02. | FluoGuide A/S Publishes Year-End and Annual Report for the Fiscal Year 2024 | 362 | ACCESS Newswire | KØBENHAVN, DENMARK / ACCESS Newswire / February 27, 2025 / FluoGuide A/S (STO:FLUO) Copenhagen, Denmark, 27 February 2025 - FluoGuide A/S ("FluoGuide" or the "Company") hereby publishes its annual report... ► Artikel lesen | |
15.01. | FluoGuide A/S Receives Approval for Phase II Trial in Head and Neck Cancer | 345 | ACCESS Newswire | KØBENHAVN, DK / ACCESSWIRE / January 15, 2025 / FluoGuide A/S (STO:FLUO) Copenhagen, Denmark - FluoGuide A/S ("FluoGuide" or the "Company"), a biotech company specializing in precision cancer surgery... ► Artikel lesen | |
27.11.24 | FluoGuide A/S: FluoGuide A/S publishes interim report for the period January - September 2024 | 276 | GlobeNewswire (Europe) | Copenhagen, Denmark, 27 November 2024 - Fluoguide A/S ("FluoGuide" or the "Company") today releases its results for the period 1 January 2024 - 30 September 2024. The Q3 report is available as attached... ► Artikel lesen |
Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
---|---|---|---|---|---|
PRIVIA HEALTH GROUP | 24,460 | 0,00 % | Privia Health Group, Inc.: Privia Health Reports Second Quarter 2025 Financial Results | Very Strong First Half Performance Across All Key Operating and Financial MetricsImplemented Providers +13.8% and Practice Collections +18.5% compared to 2Q'24Guidance Raised to Above High End of... ► Artikel lesen | |
GENEDX | 117,37 | 0,00 % | GeneDx announces first genomic newborn screening initiative | ||
PROCEPT BIOROBOTICS | 34,800 | 0,00 % | PROCEPT BioRobotics Reports Second Quarter 2025 Financial Results and Increases 2025 Revenue Guidance | SAN JOSE, Calif., Aug. 06, 2025 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics® Corporation (Nasdaq: PRCT) (the "Company"), a surgical robotics company focused on advancing patient care by developing transformative... ► Artikel lesen | |
SIEMENS HEALTHINEERS | 47,170 | +0,55 % | Hohe Investitionen und Strafen - SAP, Siemens, Siemens Healthineers, Vidac Pharma | Langsam zeichnet sich eine Erholung in der Robotik-Branche ab, nachdem die Umsätze über lange Zeit stagnierten. Dennoch spüren die europäischen Roboter-Hersteller den Druck aus China, die nun auch nach... ► Artikel lesen | |
ALIGNMENT HEALTHCARE | 16,045 | 0,00 % | Alignment Healthcare USA, LLC: Alignment Health Unveils 2026 Medicare Advantage Plans with Strong Benefits, Expanded Support for Seniors | ORANGE, Calif., Oct. 01, 2025 (GLOBE NEWSWIRE) -- Alignment Health Plan, an award-winning Medicare Advantage (MA) plan from Alignment Health, today announced its 2026 product portfolio, offering 68... ► Artikel lesen | |
BRIGHTSPRING HEALTH SERVICES | 28,730 | 0,00 % | BrightSpring Health Services, Inc. Reports First Quarter 2025 Financial Results and Increases Full Year 2025 Guidance | LOUISVILLE, Ky., May 02, 2025 (GLOBE NEWSWIRE) -- BrightSpring Health Services, Inc. ("BrightSpring" or the "Company") (NASDAQ: BTSG), a leading provider of home and community-based health services... ► Artikel lesen | |
HEARTFLOW | 36,140 | 0,00 % | HTFL Gains FDA Clearance & Cigna Coverage for Next Gen Plaque Analysis | ||
BETA BIONICS | 20,490 | 0,00 % | Forecasting The Future: 4 Analyst Projections For Beta Bionics | ||
GERRESHEIMER | 37,020 | +1,15 % | Gerresheimer, Hensoldt, Hugo Boss, MTU Aero Engines, Sartorius, Suss MicroTec - Aktien-Positionen der Short-Seller | Wer Aktien leerverkauft, also auf fallende Kurse spekuliert (Shortselling), unterliegt bestimmten Transparenzpflichten. Aktuelle Meldungen über Leerverkäufe geben Aufschluss darüber. Diese Vorgaben... ► Artikel lesen | |
AIRSCULPT TECHNOLOGIES | 7,960 | 0,00 % | Airsculpt Technologies, Inc.: AirSculpt Technologies Reports First Quarter Fiscal 2025 Results and Full Year Guidance | MIAMI BEACH, Fla., May 02, 2025 (GLOBE NEWSWIRE) -- AirSculpt Technologies, Inc. (NASDAQ:AIRS)("AirSculpt" or the "Company"), a national provider of premium body contouring procedures, today announced... ► Artikel lesen | |
FRESENIUS | 47,260 | +0,53 % | ROUNDUP/Aktien Frankfurt Schluss: Dax setzt wieder zurück - Richtungssuche | FRANKFURT (dpa-AFX) - Nach den leichten Gewinnen am Vortag hat der Dax am Donnerstag wieder den Rückwärtsgang eingelegt. Als Belastung für die hiesigen Börsen erwiesen sich zeitweise vor allem die... ► Artikel lesen | |
MIMEDX | 6,710 | 0,00 % | MiMedx Group, Inc: MIMEDX Announces Record Second Quarter 2025 Operating and Financial Results | Highest Quarterly Net Sales in MIMEDX History Second Quarter Net Sales of $99 million Grew 13% Year-Over-Year Second Quarter GAAP Net Income and Diluted Earnings Per Share were $10 Million and $0.06... ► Artikel lesen | |
RXSIGHT | 8,560 | 0,00 % | Pre-market Movers: Basel Medical Group, SOBR Safe, ProKidney, RxSight, Mustang Bio | OTTAWA (dpa-AFX) - The following are some of the stocks making big moves in Wednesday's pre-market trading (as of 08.05 A.M. ET).In the Green Basel Medical Group Ltd (BMGL) is up over 88% at... ► Artikel lesen | |
PROGYNY | 20,540 | 0,00 % | A Healthcare Debate: Progyny vs. Hims & Hers | ||
CLEARPOINT NEURO | 25,040 | 0,00 % | ClearPoint Neuro, Inc.: ClearPoint Neuro Announces Development and Demonstration of the Company's Proprietary Robotic Neuro-Navigation System | New Product Category Will Enable Added Flexibility to Support Commercial Launches of Cell and Gene Therapy SOLANA BEACH, CALIFORNIA / ACCESS Newswire / October 1, 2025 / ClearPoint Neuro, Inc. (Nasdaq:CLPT)... ► Artikel lesen |